Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries
Jonathan S. Nguyen‐Van‐Tam, Maureen A. O’Leary, Emily T. Martin, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220105-220105
Open Access | Times Cited: 115

Showing 76-100 of 115 citing articles:

Key Challenges to Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Southeast Asia, the Middle East, and North Africa: An Expert Perspective
Hakan Günen, Ashraf Alzaabi, Abdelaziz Bakhatar, et al.
Advances in Therapy (2024) Vol. 41, Iss. 11, pp. 4312-4334
Open Access | Times Cited: 1
Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, South Africa, 2012 – 2018
Jocelyn Moyes, Stefano Tempia, Sibongile Walaza, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Respiratory Syncytial Virus (RSV): Independent Community Pharmacy Impact in Promoting Prevention Through Immunization
Angelina Vascimini, Maryam Deravi, Grégoire Perez, et al.
Journal of Pharmacy Technology (2024)
Closed Access | Times Cited: 1
Bivalent RSVpreF Vaccine in Adults 18 to <60 Years Old With High-Risk Conditions
Mark M. Davis, William Towner, Elliot DeHaan, et al.
Clinical Infectious Diseases (2024)
Closed Access | Times Cited: 1
Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment
Charles Reynard, James Campling, Adam Gordon, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 1052-1067
Open Access | Times Cited: 1
Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations
Jiqian Xu, Wanying Zhang, Jiaji Fu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 1
The Molecular Basis of Asthma Exacerbations Triggered by Viral Infections: The Role of Specific miRNAs
Natalia Kierbiedź-Guzik, Barbara Sozańska
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 120-120
Open Access | Times Cited: 1
The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review
Roberto Debbag, Deborah Rudin, Francesca Ceddia, et al.
Infectious Diseases and Therapy (2024)
Open Access | Times Cited: 1
Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2 with Consideration of Older Adults: A Narrative Review
William P. Hanage, William Schaffner
Infectious Diseases and Therapy (2024)
Open Access | Times Cited: 1
Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine
Harrison C. Bergeron, Jackelyn Murray, Maria G. Juarez, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Development of a Melting-Curve-Based Multiplex Real-Time PCR Assay for the Simultaneous Detection of Viruses Causing Respiratory Infection
Eliandro Reis Tavares, Thiago Ferreira de Lima, Guilherme Bartolomeu-Gonçalves, et al.
Microorganisms (2023) Vol. 11, Iss. 11, pp. 2692-2692
Open Access | Times Cited: 4
World Pneumonia Day 2023: the rising global threat of pneumonia and what we must do about it
Catia Cillóniz, Charles S. Dela Cruz, Walter H. Curioso, et al.
European Respiratory Journal (2023) Vol. 62, Iss. 5, pp. 2301672-2301672
Closed Access | Times Cited: 4
Advanced fluorescence microscopy in respiratory virus cell biology
Enyu Xie, Shazeb Ahmad, Redmond P. Smyth, et al.
Advances in virus research (2023), pp. 123-172
Closed Access | Times Cited: 3
Concomitant Administration of Ad26.RSV.preF/RSV preF Protein Vaccine and High-Dose Influenza Vaccine in Adults 65 Years and Older: A Noninferiority Trial
Widagdo Widagdo, Arangassery Rosemary Bastian, Archana Jastorff, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 2, pp. e374-e383
Open Access | Times Cited: 3
Back to the future of viruses: a case of triple coinfection caused by respiratory syncytial virus, human coronavirus OC43, and rhinovirus
Benjamin Davido, Karim Jaffal, Elyanne Gault, et al.
International Journal of Infectious Diseases (2023) Vol. 130, pp. 205-207
Open Access | Times Cited: 2
Association between Underlying Conditions, Multimorbidity, and Covid-19 Vaccination Status of Older Adults in Beijing, China
Yuping Duan, Luodan Suo, Xiaomei Li, et al.
(2024)
Closed Access
A Case of an 86-Year-Old Male Survivor with Human Respiratory Syncytial Virus and SARS-CoV-2 Virus Coinfection
Lan Wang, Jinren Pan, Yajie Fu, et al.
Deleted Journal (2024) Vol. 6, Iss. 8, pp. 148-150
Open Access
Disease burden attributable to respiratory syncytial virus outbreaks in long-term care
Christina Ferrante, Christina Bancej, Nicole Atchessi
Canada Communicable Disease Report (2024) Vol. 50, Iss. 1/2, pp. 25-34
Open Access
Fardeau de la maladie imputable aux éclosions de virus respiratoire syncytial dans les établissements de soins de longue durée
Christina Ferrante, Christina Bancej, Nicole Atchessi
Relevé des maladies transmissibles au Canada (2024) Vol. 50, Iss. 1/2, pp. 29-39
Open Access
Burden of Disease of Respiratory Syncytial Virus in Older Adults and Adults Considered at High Risk of Severe Infection
Elissa M. Abrams, Paméla Doyon-Plourde, Phaedra Davis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Respiratory Syncytial Virus in Children: A Comprehensive Review on Publication Trends, Epidemiology, Pathogenesis, Vaccines, and Prevention Strategies
Sreedasyam Sreedevi, Gudikandula Krishna
Infectious diseases (2024)
Open Access
The Changing Detection Rate of Respiratory Syncytial Virus in Adults in Western Australia between 2017 and 2023
David A. Foley, Cara Minney‐Smith, Andrew Tjea, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 656-656
Open Access
Respiratory syncytial virus-associated respiratory diseases in children and adults
Tobias Tenenbaum, Johannes Liese, Tobias Welte, et al.
Deutsches Ärzteblatt international (2024)
Open Access
Estimating the Undetected Burden of Respiratory Syncytial Virus Hospitalizations in Adults Through Capture–Recapture Methods
Amanda C. Howa, Yuwei Zhu, Dayna Wyatt, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 5
Open Access
Role of human challenge trials (HCTs) in drug development for respiratory syncytial virus (RSV)
Prosenjit Kundu, Mark Quinn, Jared C. Christensen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Scroll to top